MIRANDA COZZONE: Open Payments
NPI 1992255699 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 11 payments from 6 companies in 2025. Trend: 2023 $381 · 2024 $292 · 2025 $440
Food & beverage: $305Education: $135
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $170 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| SOBI, INC | 1 | $33 |
| Melinta Therapeutics, LLC | 1 | $25 |
| Kite Pharma, Inc. | 1 | $17 |
Products named: PREVYMIS, IMFINZI, Vonjo, Rezzayo, Xospata, Yescarta, Cresemba.
Industry payments across AL — which companies pay providers there.
